Shanghai Pharmaceuticals. 

$7.34
4
-$0.26-3.42% Monday 20:00

統計

當日最高
7.6
當日最低
7.6
52週高點
8.32
52週低點
7.07
成交量
400
平均成交量
131
市值
27.22B
本益比
6.38
股息殖利率
4.65%
股息
0.34

即將到來

股息

4.65%股息殖利率
Feb 26
$0.08
Sep 25
$0.20
Nov 24
$0.06
Sep 24
$0.28
Sep 23
$0.42
10年成長
3.15%
5年成長
-1.58%
3年成長
-6.82%
1年成長
19.07%

財報

28Aug預期
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
下一步
0.19
0.41
0.62
0.84
預期EPS
0.5718686259
實際EPS
不適用

財務

2.02%利潤率
有盈利
2020
2021
2022
2023
2024
2025
39.49B營收
799.26M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 SHPMY 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Shanghai Pharmaceuticals Holding Co., Ltd. operates as an investment holding enterprise deeply embedded in China's pharmaceutical and healthcare industries. The company oversees a full range of activities, from the research and development of new drugs to their manufacturing, nationwide distribution, and retail sales of a diverse array of pharmaceutical and health-related products. Its operations are strategically managed across four primary divisions: Production, Distribution, Retail, and Other services. The company's extensive product catalog includes chemical compounds, biochemicals, traditional Chinese remedies, general healthcare items, and medical devices. These offerings are designed to address a broad spectrum of medical conditions, encompassing oncology, cardiovascular and cerebrovascular issues, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory conditions. Notably, their portfolio boasts over 700 distinct pharmaceutical formulations. Beyond product development and manufacturing, Shanghai Pharmaceuticals is a significant player in comprehensive pharmaceutical supply chain management. This involves sophisticated distribution, warehousing, logistics, and various value-added services, all provided to a wide range of clients including drug manufacturers and healthcare providers such as hospitals, other wholesalers, and individual retail pharmacies. Moreover, the company maintains a substantial retail footprint, managing an extensive network of roughly 2,000 chain pharmacies spread across 24 provinces, alongside a thriving online drug commerce platform. Its diverse service offerings further extend to consulting, asset management, facilitating clinical trials, offering medical assistance, educating both medical professionals and patients, handling electronic prescriptions, and pioneering remote and cloud-based hospital solutions. Established in Shanghai in 1994, Shanghai Pharmaceuticals Holding Co., Ltd. functions as a subsidiary under Shanghai Pharmaceutical (Group) Co., Ltd.
Show more...
執行長
Mr. Qiuhua Yang
員工
49608
國家
中國
ISIN
US81943R1005

上市

0 Comments

分享你的想法

FAQ

Shanghai Pharmaceuticals. 今天的股價是多少?
SHPMY 目前價格為 $7.34 USD,過去 24 小時下跌了 -3.42%。在圖表上更密切關注 Shanghai Pharmaceuticals. 股票的表現。
Shanghai Pharmaceuticals. 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 OTC Link 交易所,Shanghai Pharmaceuticals. 的股票以代號 SHPMY 進行交易。
Shanghai Pharmaceuticals. 的股價在上漲嗎?
SHPMY 股票較上週上漲 +0%,本月下跌 -3.42%,過去一年 Shanghai Pharmaceuticals. 下跌 -1.87%。
Shanghai Pharmaceuticals. 的市值是多少?
今天 Shanghai Pharmaceuticals. 的市值為 27.22B
Shanghai Pharmaceuticals. 下一次財報日期是什麼時候?
Shanghai Pharmaceuticals. 將於 August 28, 2026 公布下一次財報。
Shanghai Pharmaceuticals. 上一季度的財報如何?
SHPMY 上一季度的財報為每股 0.06 USD,預估為 0.05 USD,帶來 +7.64% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Shanghai Pharmaceuticals. 去年的營收是多少?
Shanghai Pharmaceuticals. 去年的營收為 39.49BUSD。
Shanghai Pharmaceuticals. 去年的淨利是多少?
SHPMY 去年的淨收益為 799.26MUSD。
Shanghai Pharmaceuticals. 會發放股息嗎?
是的,SHPMY 的股息每 半年一次 發放一次。每股最新股息為 0.08 USD。截至今日,股息殖利率(FWD)% 為 4.65%。
Shanghai Pharmaceuticals. 有多少名員工?
截至 July 21, 2026,公司共有 49,608 名員工。
Shanghai Pharmaceuticals. 位於哪個產業?
Shanghai Pharmaceuticals.從事於Health & Wellness產業。
Shanghai Pharmaceuticals. 何時完成拆股?
Shanghai Pharmaceuticals. 最近沒有進行任何拆股。
Shanghai Pharmaceuticals. 的總部在哪裡?
Shanghai Pharmaceuticals. 的總部位於 中國 的 Shanghai。